Zhou Hui-Ling, Han Ming-Zhu, Nan Miao-Miao, et al. Isodons A-H, seco-abietane and abietane-type diterpenoids from Isodon lophanthoides: isolation, structural elucidation, and anticholestatic activity [J].Chin J Nat Med, 2024, 22(0): 1-14. DOI: 10.1016/S1875-5364(24)60686-2
Citation: Zhou Hui-Ling, Han Ming-Zhu, Nan Miao-Miao, et al. Isodons A-H, seco-abietane and abietane-type diterpenoids from Isodon lophanthoides: isolation, structural elucidation, and anticholestatic activity [J].Chin J Nat Med, 2024, 22(0): 1-14. DOI: 10.1016/S1875-5364(24)60686-2

Isodons A-H, seco-abietane and abietane-type diterpenoids from Isodon lophanthoides: isolation, structural elucidation, and anticholestatic activity

  • Isodons A-H (18), 11 new seco-abietane and abietane-type diterpenoids, along with 13 known analogues (921), were obtained from Isodon lophanthoides (Buch.-Ham. ex D. Don) Hara. Compounds ( + )-3/(−)-3, ( + )-4/(−)-4, and ( + )-5/(−)-5 were three pairs of enantiomers. HRESIMS, 1D & 2D NMR, ECD calculations, and X-ray diffraction crystallography data confirmed the planar structures and absolute configurations of 18. Cholesterol 7α-hydroxylase (Cyp7a1) luciferase reporter assay showed that compounds 1, ( + )-4, 6, 7, 1214, and 16 displayed potent anticholestatic activities. Moreover, compound 6 exerted anticholestatic effect via the farnesoid X receptor (FXR)-associated signaling pathways in vitro and in vivo. These results provided an important reference value for the new application of I. Lophanthoides in medical industry.
  • loading

Catalog

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return